Although phase III trials constitute stronger evidence to show efficacy or lack thereof, it is crucial to look critically at these results
Nhiu bnh nhn bt u nhn thy s ci thin v mc nng lng v s t tin trong vng ba thng u iu tr
Oligofructose promotes satiety in healthy human: a pilot study
High-dose use While trials have tested up to 1200mg/day (even as high as 2400mg/day) and illustrated safety, some report higher rates of gastrointestinal side effects, dizziness, and skin reactions at these levels.14 28 38 Additionally, these higher doses are often short-term (35 weeks) and used under clinical supervision
In addition, Novo Nordisk provided financial support for medical writing assistance, but had no role in the writing, revision, or submission of the present article